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Effects of Organometals on Cellular Signaling.
I. Influence of Metabolic Inhibitors on Metal-
induced Arachidonic Acid Liberation
Andrea Kafer and Harald F. Krug
Kernforschungszentrum Karlsruhe, Institute ofToxicology, Karlsruhe, Germany
Organic lead and tin compounds stimulate an increase of free arachidonic acid (AA) in HL-60 cells. This fatty acid is involved in numerous health
problems and physiological mechanisms. Three major pathways result in a liberation of AA from membrane phospholipids and there is evidence that
G-proteins serve as couplers within all three pathways. Therefore we investigated the influence of pertussis toxin (PT) on the organometallic-
induced AA liberation. The effect of all studied compounds (organotin and organo-lead) was diminished by PT. We conclude that the organometals
activate PLA2 to some extent via a PT-sensitive pathway. The ionophor A 23187 (1-10 pM) led to an increase of free AA by raising the intracellular
Ca2, level. One of the postulated ways of AA release is via Ca2, channel activation; phospholipases are Ca2' dependent. Thus, we examined the
necessity of free intracellular Ca2, for the organometallic effect. The Ca2' chelator EGTA inhibited the increase of free AA induced by organometals.
This is true also for verapamil, a Ca2+ channel blocker. Quinacrine, which is thought to be an inhibitor of phospholipase A2 (PLA2), prevented the AA
liberation from membrane phospholipids induced by organometals. This could be due to the inhibition of PLA2, but it could also be the result of an
inhibited Ca influx. - Environ Health Perspect 102(Suppl 3):325-330 (1994).
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Introduction
Many organometallic products are directly
applied to the environment, e.g., as bio-
cides, as antifouling paints, or as gasoline
additives (1). Thus, they are ubiquitously
distributed toxins, some ofwhich can accu-
mulate in the body (2). However, less
attention has been paid to chronic, nonfa-
tal exposures to such toxic compounds.
Arachidonic acid (AA) and a number of
its biologically active products are gener-
ated in response to many physiologic and
pathologic stimuli and also in response to
several metallic and organometallic com-
pounds (3-7). The importance of AA in
the induction oflong-term potentiation, in
the modulation of signal transduction, in
the regulation of enzyme activities, and in
intracellular Ca homeostasis is well
known (8). In most cells, including HL-60
cells, AA is not normally found in a free
form. The liberation of AA from its sn-2
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position in membrane phospholipids limits
the synthesis of eicosanoids and other bio-
logically active metabolites. The concept
that changes in phospholipase activity are
responsible for controlling free AA levels is
generally accepted (9S.
There are three physiologic pathways to
increase free AA. First, the activation of
phospholipase C (PLC) hydrolyzes phos-
phatidylinositol (PI) to inositoltrisphos-
phate (IP3) and diacylglycerol (DAG). In a
second step, diacylglycerol lipase liberates
AA from DAG. IP3 and DAG as second
messengers increase the cytosolic Ca2+ con-
centration, and activate protein kinase C.
Second, the activation ofphospholipase A2
(PLA2) directly leads to an increase of free
AA and subsequent metabolization. Third,
activated Ca2, channels increase the intra-
cellular Ca2+ concentration. Most of phos-
pholipases are Ca2+ dependent, but that
does not necessarily mean they are Ca2+
controlled.
In neutrophils, the second pathway (via
PLA2) has been thought to be primarily
responsible for the liberation of AA (10).
There is evidence to suggest that G-pro-
teins serve as couplers within all three men-
tioned pathways. Several studies have
shown recently that treatment with pertus-
sis toxin (PT) inhibits AA release in various
cells, suggesting a G-protein-mediated
stimulation ofAA liberation (11,12).
The present study was undertaken to
gain more insight into the mechanism(s) of
organometallic-induced AA release. The
first step was to investigate the influence of
PT. This exotoxin, produced by Bordetella
pertussis, is one of the A-B toxins. The B-
oligomer (binding subunit) binds at the
cell surface to permit the A-protomer (cat-
alytic subunit) to reach the intracellular
site. The A-protomer catalyzes ADP-ribo-
sylation of the a-subunit of G-proteins.
Thereby, G-proteins lose their function.
PLA2 is known to require Ca2+ for
activity. Thus, we wanted to clarify
whether there is any effect ofCa2+ availabil-
ity on the organometallic-induced AA lib-
eration. We examined the necessity of free
extracellular Ca2+ by the use ofEGTA-con-
taining medium, and the involvement of
Ca2+ channels by blocking them with vera-
pamil, a substance which is in pharmaco-
logic use. Quinacrine is used as an
inhibitor of PLA2 (13,14). Lacking a real
PLA2 inhibitor (15), we examined the
influence of quinacrine on the organo-
metallic-induced AA liberation, keeping in
mind that this substance alters Ca2+ homeo-
stasis also.
Materials and Methods
Chemicals
All organometals were obtained from
Ventron Alfa Products (Karlsruhe,
Germany). Dibutyltin (Bu2SnCl2) and
trimethyllead (Me3PbCl) were used with-
out further purification; triethyllead
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Figure 1. Influence of PT and its B-oligomer on organometal-induced arachidonic acid release. Suspensions of radioac-
tive labeled, differentiated HL-60 cells were preincubated with PT or its 13-oligomer for 3 hr before fMLP, A 23187 or
organometals were added as indicated on the abscissa. Dotted line: control stimulation without pretreatment. Cellular
lipids were extracted after the times indicated and arachidonic acid was separated by thin-layer chromatography
Identification of lipids was performed by use of commercial lipid standards. The amount of liberated arachidonic acid
wascomparedtothatofvehicle-treated HL-60cells(1(00%).Valuesarethe meanof7to 12experiments ±SD.
(Et3PbCl) has been purified. Pertussis
toxin, verapamil, fMLP, and calcium
ionophore A 23187 were from Sigma
(Munich, Germany) and the SIL G -
Polygram thin-layer plates from
Macherey & Nagel (Duren, Germany).
EGTA, nitro blue tetrazolium chloride,
trypan blue dye, and quinacrine were pur-
chased from Serva (Heidelberg, Germany).
The [1-14C]-arachidonic acid
(2.07 GBq/mmole) was purchased from
Amersham (Braunschweig, Germany).
The pertussis toxin j-oligomer was from
List Biological Laboratories (Campbell,
CA). All other chemicals were of analytic
grade.
CellCultureandIncubation
The HL-60 cells were expanded from
stocks frozen in liquid nitrogen and were
grown in suspension culture in RPMI 1640
medium supplemented with 15% heat-
inactivated fetal calf serum. The suspen-
sions were split twice a week to maintain
cell number between 2 x 105 and
2 x 106 cells/ml. They were induced to dif-
ferentiate into mature granulocytes by the
addition of 1.3% dimethyl sulfoxide for 5
to 6 days.
The percentage of differentiated cells
was quantified using the nitroblue tetra-
zolium reduction method as described
(16); if the extent of differentiation
exceeded 70%, the cells were used for the
experiments.
[1-_4C]Arachidonic acid (92.5 kBq)
was added at day 5 to 50 ml culture
medium, and 3 x 108 cells were incubated
overnight (7,17). The labeled cells were
harvested by centrifugation, washed once
with RPMI without additives, and resus-
pended in medium containing 3.3% heat-
inactivated fetal calf serum (and, if
necessary 5 mM EGTA) at a concentration
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of 0.75 x 107 cells/ml. Experiments were
started after a 30-min resting time. The cell
suspensions (2 ml) were then incubated at
37°C with the different organometal com-
pounds, fMLP or A 23187 and addition-
ally PT, 3-o6ligomer, EGTA, verapamil, or
quinacrine in the concentrations indicated.
Verapamil and quinacrine were added to
the labeled cells 5 to 10 min before the
organometals. In the case of PT- or PT-B-
oligo-pretreatment ofcells, the organomet-
als were added 3 hr later.
Stock solutions of Et3PbCl, Me3PbCl,
quinacrine, and verapamil (20 mM each)
were prepared in deionized water, whereas
Bu2SnCl2, A 23187, and fMLP had to be
dissolved in dimethyl sulfoxide (20 mM).
The final concentration ofdimethyl sulfox-
ide within the incubation mixture did not
exceed 1.3%. EGTA was dissolved in the
incubation medium (see above), and [1-
14C]Arachidonic acid was dissolved in
dimethyl sulfoxide.
Viability
Cell viability was determined by try-
pan blue exclusion. The number of
blue cells was estimated using a
Neubauer-chamber subsequently mix-
ing the cell suspension with the dye
solution. The organometal concentra-
tions within the incubation mixtures
did not decrease cell viability below
80% of control during the incubation
time.
Bu2SnCI2
500 [lm]
60 [min]
Figure Inhibition of organometal-induced arachidonic acid release by the Ca2+ chelator EGTA. ['4C]-arachidonic acid
prelabeled, differentiated HL-60 cells were resuspended in EGTA-containing medium (5mM)and incubated with different
organometals as indicated. At the end of the incubation period (indicated at the abscissa) cellular lipids were extracted
and separated bythin-layerchromatography. The amountofAAwasexpressed as percentoftotal incorporated radioactiv-
ity. Values arethe mean ± SEM offive to seven experiments. Statistical significance: **=0.0005 > p, comparedwithvehi-
cletreatedcontrols, ## =0.005 > p>0.0005,#=0.05 >p>0.001,comparedwithcontrol stimulations(unpaired t-test).
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Figure3. EffectofCa2+channel blockerverapamil on arachidonic acid liberation byorganometals. Afterpreincubation of
radioactive labeled, differentiated HL-60 cellswith 100 pmverapamil (5-10min), organometals were added as indicated
(Figure 2). Values are the mean ± SEM offive to eight experiments. Statistical significance: **= 0.0005 > p, compared
withvehicle-treated controls and #=0.05 > p>0.001,comparedwith control stimulations(unpairedt-test).
lipid Ection andSeparation
After incubation of the cell suspensions
(2 ml) they were extracted according to the
method ofKrug and Culig (7) by addition
of 7.5 ml chloroform/ methanol (1:2) and
phase separation was induced with further
2.5 ml chloroform and 2.5 ml 0.2% formic
acid. After 5 min on ice, this mixture was
centrifuged at 300g to 400g for 5 min. The
organic phase was dried under nitrogen
and taken up in a small volume of chloro-
form.
The lipid extracts were spotted onto
SIL G polyester plates and separated into
lipid classes by thin-layer chromatography
(TLC) as described earlier (7). Labeled
products were located by autoradiography,
and the appropriate regions of the plates
were cut out and counted for radioactivity
in a 1219 Rackbeta liquid scintillation
counting system (LKB Freiburg,
Germany).
Resufts
HL-60 cells, differentiated with 1.3%
dimethyl sulfoxide into mature granulo-
cytes, were incubated for 24 hr in the pres-
ence of [14C]-arachidonic acid. An
equilibrium in arachidonic acid distribu-
tion within the lipid classes was reached
after 24 hr (7,141.
Upon stimulation with A 23187,
fMLP, and various organometals, HL-60
cells showed increased levels offree arachi-
donic acid (18-20). The effect ofdifferent
substances on the organometal-induced AA
liberation was examined.
Effect ofPT andIts -Oligomer
on Organometal Stimulation
of HL-60 Cells
Pretreatment with PT (1500 ng/ml in the
case of stimulation with organometals,
500 ng/mL in the case ofstimulation with
fMLP or A 23187) led to a reduced effect
of organometals regarding the increase of
free AA in dimethyl sulfoxide differentiated
HL-60 cells (Figure 1, crosshatched bars).
Preincubation ofthe cells with PT led to a
44% reduction of AA liberation as com-
pared to treatments with Me PbCl
(500 pM; 20 min) alone. The effect of
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Et3PbCl (100 pM; 20 min) and Bu2SnCl2
(500 pM; 60 min) was about 30%
reducible by pretreatment with PT,
whereas stimulation with fMLP (1 pM;
10 min) was decreased to 20% ofthe con-
trol stimulation. A 23187-induced (10 pM;
10 min) AA release, on the other hand, was
only25% diminished by PT (Figure 1).
The hatched bars in Figure 1 show the
influence ofI-oligomer (equimolar to PT),
the noncatalytic subunit of PT, on the
stimulation ofAA liberation. This allowed
an estimation of how much the simple
binding of a protein to the plasma mem-
brane alters the level of free AA in HL-60
cells. The AA liberation induced by the dif-
ferent stimuli was reduced, in any case, by
not more than 10%.
Influence ofEGTA Verapamil,
andQui2nacine
The effect ofEGTA (5 mM), a Ca2+ chela-
tor, is shown in Figure 2. The Ca2+ deple-
tion by EGTA decreased the AA liberation
induced by organometals. Two ofthe com-
pounds, Me3PbCl and Et3PbCl, lost their
AA liberation potency completely in the
presence of EGTA. On the contrary, the
effect of Bu2SnCl2 was only half dimin-
ished (52% reduction).
Not only EGTA but also verapamil, a
Ca2+ channel blocker, alters the organometal-
induced AA release (Figure 3). Verapamil
(100 pM) could prevent 67, 65, and 43%
of the AA release induced by Me3PbCl,
Et3PbCl, or Bu2SnCl2, respectively.
Quinacrine (1 mM), which is used as a
PLA2 inhibitor, also influences the AA lib-
C Me3PbCI Et3PbCl
500 100
20 20
Bu2SnC12
500 bum]
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Fgure 4. Influence of quinacrine on organometal-induced arachidonic acid liberation. After 5 to 10 min preincubation
with quinacrine (1 mM), organometals were added to radioactive labeled, differentiated HL-60 cells as indicated on the
abscissa. (Figure 2). Values are the mean ± SEM. of five to seven experiments. Statistical significance: **= 0.0005 > p,
compared withvehicletreated controls, # =0.005 > p>0.0005,# =0.05 > p>0.001, comparedwithcontrol stimulations
(unpaired t-test).
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eration in response to organometals
(Figure 4). The effect of the organolead
compounds (Me3PbCl and Et3PbCl) on
the AA metabolism nearly disappeared
when cells were pretreated with quinacrine.
Moreover, the effect of the tin compound
was decreased by this substance only to
54%. This inhibitory effect of quinacrine
was similar to the results obtained with
Ca2, chelating by EGTA.
Discussion
Because the use oforganometals is still very
widespread and the environmental pollu-
tion is increasing, the effects within living
organisms have not been sufficiently inves-
tigated. It is possible that some intracellular
effects of alkylmetals are indirect due to
altered characteristics of the plasma mem-
brane and correlated enzymes like G-pro-
teins, adenylate cyclase, and
phospholipases. Within the last 20 years
the importance of phospholipases in bio-
logic processes has been recognized. In par-
ticular, PLA2 has attracted much attention
because of its ability to produce substrates
for the generation of inflammatory lipid
mediators. The sources of these potent,
biologically active substances (like
eicosanoids, paf-acether, lysophospho-
lipids) are phospholipids found in the cel-
lular membranes. Investigations into the
influence of organometals on eicosanoid
metabolism in platelets or cultured cells
have been reported by several groups
(3-7,20).
G-protein regulation has been demon-
strated for several membrane-associated sig-
nal-transducing-systems, including
phospholipases and ion channels [phospho-
lipases (12,21); ion channels (22,23)]. The
bacterial toxin PT has been widely used as
a tool to demonstrate the involvement of
G-proteins in signal transduction. To esti-
mate if G-proteins are involved in the
organometallic-induced AA liberation in
dimethyl sulfoxide differentiated HL-60
cells, we examined the inhibitory potency
of PT and its ,B-oligomer on this effect
(Figure 1). We found that the release ofAA
from membrane phospholipids induced by
organometals could be reduced by pretreat-
ment with PT as described earlier (7). The
inhibition ofthe signal transduction by PT
points to an involvement ofa G-protein in
this mechanism, although the overall
inhibitory effectiveness varies over a wide
range within cell cultures ofdifferent origin
(7) (Figure 1). It clearly shows that the
effect of organometals on eicosanoid
metabolism is not only due to a direct acti-
vation of either PLA2 or PLC. Although
the relative contribution of the possible
pathways to the liberation of AA (direct
activation of PLA2, indirect via activation
ofPLC, or rising Ca2+ level) is still obscure,
PLA2 is the most likely candidate responsi-
ble for AA release (8). The lack of an
inhibitory action ofthe 1-oligomer showed
that the effect mediated by the bacterial
holotoxin really resulted from the ADP
ribosylation of G-proteins and not merely
from unspecific alterations of membrane
(function) by intercalation ofthe toxin.
G-proteins may play a role in PLA2
control (8), but many other factors are also
capable of modulating the activity of the
enzyme (8,24,25). Therefore it seems likely
that there is more than one mechanism
that leads to an AA release after incubation
with organometals. Since phospholipases
are dependent on Ca2+, and Ca + channels
are known to be regulated by G-proteins,
compounds that influence cellular levels of
2+. ..... Ca were examined for inhibitory activity
in this context. Brooks et al. (26) suggest a
model for PLA2 regulation in which the
enzyme is functionally associated with
plasma-membrane Ca2+ channels. A sus-
tained increase of intracellular Ca2+ con-
centration is often linked to the onset of
cytotoxicity. Several biochemical mecha-
nisms are stimulated by an increase ofCa2+
and can directly mediate cell death by caus-
ing disruption of the cytoskeleton, by
DNA fragmentation, and by extensive
damage to other cell components (27). By
increasing free intracellular Ca2 ,
organometals might initiate chains of
events exciting and finally killing the cell.
Therefore we studied the effect of EGTA
and verapamil.
In contrast to the slight but clear effect
of PT, the depletion of extracellular Ca2+
led to total disappearance ofthe organolead
(Et3PbCl, Me3PbCl)-induced AA release in
HL-60 cells (Figure 2). All phospholipases
are known to be Ca2+dependent and Ca2+ is
a prime candidate for being a PLA2 regula-
tor because a Ca2+ binding site has been
identified on PLA2 (28). Alkylmetals cause
a linear increase in intrasynaptosomal Ca2+
after an initial rise (29). Ca2+ appears to
mediate the neurotoxicity due to cyanide,
lead, methyl mercury, chlordecone, and
organotin compounds (30). Addition of
thimerosal to human platelets causes a
sharp rise in intracellular Ca2+ (5). The
EGTA-inhibited AA liberation by
organolead could therefore be explained by
an inability to raise intracellular Ca2+ to
levels sufficient for phospholipase activity.
The observation that the Bu2SnCl2-
induced AA liberation could only be inhib-
ited to about 50% by EGTA leads to spec-
ulation that this is due to the release of
Ca2+ from intracellular stores by the organ-
otin compound (Figure 2). This was con-
firmed by measuring the intracellular Ca2+
concentration after Bu2SnCl2 treatment
using EGTA-containing medium, which
led to an intracellular increase ofCa2+ (31).
In the absence of extracellular Ca2+
(chelated by 1 mM EGTA), thimerosal still
induced a significant increase in the intra-
cellular Ca2+ (5). However, the increase of
the Ca2+ level during physiologic activation
of phospholipases is below that needed
in vitro; and the Ca2+ dependency of an
enzyme does not automatically mean that
it is under Ca2+ control. On the other
hand, sustained Ca2+ influx across the
plasma membrane could generate veryhigh
2+...... Ca concentrations in the vicinity of
membrane-associated PLA2, thus leading to
its activation. Intracellular Ca2+ is regulated
by channels, pumps, exchangers, and stores
at both plasma membrane and intracellular
sites. Thus, the mechanism by which
organometals cause an increase in cytosolic
Ca + could be at least 2-fold: first, by acti-
vating Ca2+ channels, and second, by non-
specific effects on the membrane
characteristics. Both could be followed by
an activation ofPLA2and/or PLC.
The activation of a Ca2+ channel could
be direct or via a G-protein (22,23).
Verapamil, an antihypertensive agent, is
known to block slow Ca2+ channels (32).
Fernandez and Balsinde (33) reported that
verapamil persistently inhibits AA release in
macrophages. They sugest the involve-
ment ofvoltage-gated Ca + channels in the
control ofPLA2 activation. Treatment with
verapamil diminished the organometal
effect, but did not abolish the AA libera-
tion totally (Figure 3). This could be due
to the inhibition of only certain (voltage-
gated) Ca2+ channels. Organotin-induced
AA liberation could not be inhibited in the
same range as the organolead-induced AA
liberation, perhaps due to an additional
activation of intracellular Ca2+ stores by
Bu2SnCl2 The remaining increase in free
AA in HL-60 cells could be explained by
an additional and more direct activation of
phospholipases (directly on the enzyme or
via a G-protein coupled to the phospholi-
pase) by organometals. The Ca2, antagonist
verapamil is also discussed as a PLA2
inhibitor. This has been attributed to the
formation of nonspecific drug-phospho-
lipid complexes rather than to blockage of
slow Ca2+ channels (28). The difference
between the effect of organolead and
organotin compounds could be explained
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by differences in solubility. Whereas
Et3PbCI and Me3PbC1 can be dissolved in
water, Bu2SnCl2 has to be dissolved in
organic solvents like dimethyl sulfoxide or
ethanol. This is due to the higher
lipophilicity ofBu2SnCl2 compared to the
organolead compounds. This lipophilicity
may allow the Bu2SnCl2 to reach the
intracellular stores and to mobilize Ca2+,
whereas the other substances may exhibit
their effects almost exclusively at the
plasma membrane.
Short pretreatment with quinacrine,
which is thought to be a PLA2 inhibitor
(13,14) led to significantly lower AA lib-
eration induced by organometals.
Nakashima et al. (12) report that
quinacrine effectively supresses the paf-
induced liberation of [3H]-AA from phos-
pholipids in human polymorphonuclear
neutrophils. In this case, extracellular Ca2+
is not required for AA release. The results
discussed here (Figure 4) obviously show
the same pattern as the inhibition of the
AA release by the Ca2+ chelator EGTA.
We therefore conclude that the anti-
malaria agent quinacrine operates as a
Ca2+ antagonist rather than as a PLA2
inhibitor. Stokke et al. (34) reported the
negative inotropic effects of quinacrine in
the heart. They concluded that quinacrine
binds to or close to slow Ca2+ channels.
The inhibition of PLA2 activity by
quinacrine could possibly lead to a dimin-
ished Ca2+ availability and not to a direct
inhibition ofthe enzyme itself.
Once activated, PLA2 can mediate a
variety of pathophysiologic reactions
either directly action or through subse-
quent transformation of its products into
several potent, biologically active sub-
stances such as prostaglandins,
leukotrienes, and paf. Lysophospholipids,
the coproducts of PLA2 activation, are
cytotoxic substances and membrane fuso-
gens, and have been implicated in several
human inflammatory conditions.
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